Results 231 to 240 of about 17,995 (265)
Some of the next articles are maybe not open access.

Alemtuzumab induced red cell aplasia and other immune cytopenias - not so 'pure'.

Immunotherapy, 2021
We report on the presentation and outcome of a 28-year-old female who developed red cell aplasia following alemtuzumab therapy for relapsing remitting multiple sclerosis.
L. Aitken   +3 more
semanticscholar   +1 more source

T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia

International journal of hematology, 2022
Fumihiro Kawakami   +12 more
semanticscholar   +1 more source

Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia

Annals of Hematology, 2022
Xuemei Wu   +6 more
semanticscholar   +1 more source

Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib

Bone Marrow Transplantation, 2022
Shukaib Arslan   +7 more
semanticscholar   +1 more source

Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia

International journal of hematology, 2021
Xiaoqing Liu   +8 more
semanticscholar   +1 more source

Gene mutation profile in patients with acquired pure red cell aplasia

Annals of Hematology, 2020
Z. Long   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy